Search results
Ongoing clinical trials offer hope for people born with genetic mutation behind fibrodysplasia...
Medical Xpress· 3 days agoThe team behind one such effort, with members from Blueprint Medicines Corporation, Invicro and Alexion Pharmaceuticals, all in the Boston area, have published their findings ...
Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris
RTT News· 3 days agoThe U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's ...
PA Killed in Crossfire; Doc Gets 4 Years for Insider Trading; Wrongful Death Suit
MedPage Today· 4 days agoThree suspects have been arrested in the shooting death of South Carolina physician assistant Blaine...
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters via AOL· 5 days agoAmgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex...
Poughkeepsie kidney doctor headed to prison - Mid Hudson News
Mid Hudson News· 5 days agoWHITE PLAINS – A kidney doctor with practices in Poughkeepsie, Newburgh, and Kingston was sentenced...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoInvivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that Timothy Lee will be appointed Invivyd’ ...
Biomarkers in Chronic Inflammatory Demyelinating Polyneuropathy
MedPage Today· 4 days agoChronic inflammatory demyelinating polyneuropathy (CIDP) diagnoses are frequently missed or delayed...
Invivyd appoints new Chief Commercial Officer ahead of PEMGARDA launch By Investing.com
Investing.com· 2 days agoInvivyd, Inc. (NASDAQ:IVVD), a company focused on developing treatments for viral infectious...
Monoclonal Antibody May Benefit Patients With Kidney Transplant Rejection
MedPage Today· 6 days agoAn investigational monoclonal antibody appeared to have therapeutic benefits among kidney transplant...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 2 days agoTruqap™ (capivasertib) plus fulvestrant now available in Canada Canada NewsWire MISSISSAUGA, ON, May 31, 2024 MISSISSAUGA, ON, May 31, 2024 /CNW/ - AstraZeneca is pleased to announce that Truqap™ (capivasertib) in combination with fulvestrant is